Additional file 2 of Deciphering the pharmacological mechanisms of Fraxini Cortex for ulcerative colitis treatment based on network pharmacology and in vivo studies

Additional file 2: Table S1. Active compounds of Fraxini Cortex. Table S2. Predicted targets of the Fraxini Cortex compounds. Table S3. The hub genes enriched in biological processes. Table S4. The hub genes enriched in cellular components. Table S5. The hub genes enriched in molecular function. Table S6. KEGG pathway enrichment analysis of the hub genes. Table S7. Molecular docking of four compounds for UC targets. Table S8. The mRNA expression profile of FC targets in IL-17 signaling pathway.